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Abstract
Objective. The subjective dimension of disability, the perception of disability, is a dimension missing from the International
Classiﬁcation of Functioning, Disability and Health (ICF), and from health-related quality of life (HRQOL) instruments.
However, it is a highly relevant dimension for clinical practice as perceived disability may identify care needs. We therefore
developed a measure for this subjective dimension of disability in multiple sclerosis (MS) and examined the contribution of
this dimension to QOL.
Method. A measure named the Multiple Sclerosis Impact Proﬁle-Disability Perception (MSIP-DP) was developed to reﬂect a
person’s perception of disabilities reported using the original MSIP-disability (MSIP-D) items. MS patients (n¼530)
completed both MSIP sections, the medical outcome study short form questionnaire (SF-36), the World Health Organisation
Quality Of Life-BREF (WHOQOL-BREF) and questions concerning disease severity. The contribution of disability
perception (DP) to QOL in MS was estimated using hierarchical multiple regression analyses after controlling for MS severity.
Results. Conﬁrmative factor analysis conﬁrmed the hypothesised disability perception domains that correspond with the
related disability domains in the MSIP. DP scales yielded sufﬁcient reliability. DP explained a unique and substantial part of
the variance in QOL, particularly the perception of impairments in mental functions.
Discussion. Results indicated that the subjective dimension of functioning and health operationalised in the MSIP-DP is a
relevant concept in explaining QOL in MS. In clinical practice psychological interventions addressing a patient’s perception
of disability, particularly of impairments in mental functioning, may contribute to QOL.
Keywords: Disability perception, multiple sclerosis impact proﬁle, health related quality of life, multiple sclerosis
Introduction
The International Classiﬁcation of Functioning,
Disability and Health (ICF) [1] is the re-visited
successor of the International Classiﬁcation of
Impairments, Disabilities and Health [2], that
belongs to the ‘family’ of international classiﬁcations
developed by the World Health Organisation
(WHO) and was endorsed by the World Health
Assembly in 2001. As a result of the rigorous revision
process ICF encompasses all aspects of human
health and some health-related relevant components
of well-being. As the ICF was endorsed by the
World Health Assembly as a member of the WHO
Family of International Classiﬁcations, it is likely to
become the generally accepted classiﬁcation to
describe functioning and health, and in fact already
become so.
Despite these positive and important qualities of
ICF it also has an important shortcoming. The main
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.focus of the ICF is on the objective dimension of
human function and disability and passes over the
subjective dimension, the perception of these dis-
abilities [3]. Particularly in chronic diseases a
person’s subjective perception of disease-related
disabilities is an important contributing factor to
better QOL.
Two separate cases provide examples. In the ﬁrst
case, during a period of rapid progression of the
disease, a young man became permanently depen-
dent on his wheelchair and had to give up his job. As
a consequence he was depressive and not capable to
accept the consequences and irreversibility of the
situation. In the second case of another man with
multiple sclerosis (MS) who had also a complete
limitation in walking and was retired because of MS,
the situation was much less negative. This person has
found new satisfying goals in his life, and accepted
his wheelchair as a helpful aid to keep independency.
In these examples the functional limitations, that is
the objective dimension of the situation, were the
same. However, the perception of these limitations,
that is the subjective dimension of the situation,
differed.
The objective dimension (the disabilities) and the
subjective dimension (the perception of these dis-
abilities) are inter-related and interact, but also have
a great relative independence from each other as
illustrated in the example. Consequently, both
dimensions should be integrated into a coherent
whole of human functioning and disability [3].
It is a misunderstanding that health-related quality
of life (HRQOL) measures enable the assessment of
this missing subjective dimension of ICF. This is
only partially true as these measures focus on both
dimensions of human life and combine items
focusing on either the objective dimension (e.g.
items concerning functioning) or the subjective
dimension (e.g. items concerning satisfaction with
social life). Furthermore, QOL measures were
developed for clinical purposes and had to be
practical. As a consequence QOL constructs are
not developed in a systematical way as ICF is [3].
Therefore, integration of ICF and QOL measure-
ments reﬂecting both objective and subjective
dimensions of human functioning, disability and
health into one classiﬁcation system would be a great
step forward in understanding QOL. Several models
were proposed to integrate both dimensions onto
ICF [3,4].
In this study, an attempt is made to integrate both
dimensions of functioning and health into one
measure for people with MS. MS is a chronic,
demyelinating, neurodegenerative disorder of the
central nervous system. Its onset is usually in early
adulthood and the course of the disease is often
progressive and debilitating [5]. As a consequence,
MS-related disabilities have a profound impact on
all aspects of QOL. Therefore, receiving insight
into both, a person’s disabilities and his or her
perception of these disabilities, is a relevant issue
in QOL research and in health care for people
with MS.
In summary, the objectives of this study were (1)
to develop a measure reﬂecting the subjective
dimension of functioning and health, the percep-
tion of MS-speciﬁc disabilities; and (2) to examine
the unique contribution of this subjective dimen-
sion of MS-related disabilities to QOL, as we
hypothesised that, apart from the disabilities, the
perception of disabilities explains a relevant and
statistically signiﬁcant part of QOL in MS. We
controlled for disease severity (as an estimate for
disability) in analysing the impact of disability
perception (DP) on QOL.
Method
Samples and procedures
We applied a postal survey in two samples of MS
patients (see Table I): members of the MS Patient
Association (PA sample) in the northern parts of the
Netherlands, and patients from the Groningen MS
centre, which is part of the Neurology Department of
the University Hospital (UH sample). Respondents
could not participate in both samples.
Of the 172 questionnaires sent out in the PA
sample, 153 questionnaires (89% response rate) were
returned and used for analyses. Of the 562 patients
in the UH sample, 377 patients (67% response rate)
completed the questionnaires. Non-responders in
both samples did not differ in age and gender from
participating patients. Respondents in both samples
completed the Multiple Sclerosis Impact Proﬁle
(MSIP) [7] with the linked DP questions, the World
Health Organisation Quality of Life (abbreviation
version) (WHOQOL-BREF) [8] and demographic
and disease severity questions. In addition, respon-
dents in the PA sample also completed the Medical
Outcome Study Short Form Questionnaire (SF-36)
[9]. Data for the test-retest analysis on the DP scales
was obtained from a UH sub-sample. Of the 279
patients who agreed to ﬁll out the items twice, at a 2
month interval, 251 returned the questionnaire (90%
response rate). Non-respondents in the test-retest
sample did not differ in age or gender from
participating patients.
The local University Hospital Medical Ethics
Committee approved the study protocols of both
studies. Written informed consent from respondents
in both samples was obtained.
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.Measures
Disability perception measure
We wanted to evaluate the subjective dimension or
perception of disabilities of each individual patient
for each separate MS-related disability. We therefore
used the validated MSIP [7,10] that reﬂects the
prevalence and severity of MS-related disabilities,
and linked a DP question to each ‘disability’ (D)
question. We developed a new measure with these
items and named this section of the MSIP the MSIP-
Disability Perception (MSIP-DP) section, whereas
the original section of the measure is denoted as
MSIP-Disability section (MSIP-D).
The MSIP-D section consists of 36 items with
seven scales covering the ICF domains for body
functions, activities, participation and environmental
factors, and four single impairment items. DP
questions were directly linked to each MSIP-D
question. MSIP-D questions were phrased (for
example) ‘Do you face impairments in ... ’ Next,
the DP question for each disability was: ‘Do you
perceive this disability as problematic?’ Response
options were (0¼No, Never; 1¼Yes, Sometimes;
2¼Yes, Frequently; and 3¼Yes, Always. Only
when a disability was reported, the patient was asked
to answer the linked DP question on the degree to
which that speciﬁc disability was perceived as a
problem (see Addendum). When a patient reported
having no disability, the DP question was skipped.
Before scale construction, ‘missing’ values to the
perception questions resulting from reporting ‘no
disability’, were recoded with a ‘zero’ score.
Summed scores for the hypothesised MSIP-DP
domains indicate the extent to which patients
perceive the reported disabilities as problematic. A
lower DP score means that a reported disability is
perceived as less problematic.
Measures of disease severity
Disease severity was measured through self-report
questions on (1) disease duration; (2) extent of
limitations due to MS; and (3) disease progression.
Disease duration was measured by the period of time
that had elapsed since deﬁnite diagnosis was made by
a neurologist. To assess the extent of limitations,
respondents were asked: ‘To what extent are you
limited due to MS?’ on a 10-point scale with a score
ranging from 1 (not limited at all) to 10 (severely
Table I. Patient characteristics from total sample and test-retest sample.
Variable PA sample UH sample
Differences
PA and UH samples
Total
sample
Test-retest
sample
Differences
UH and test-retest
samples
N 153 377 530 251
Gender N (%)
Female 114 (75) 261 (69) 0.24* 375 (71) 182 (73) 0.04*
Male 39 (25) 116 (31) 155 (29) 69 (27)
Age
Mean (SD) 49 (9) 49 (12) 0.06
{ 50 (12) 51 (11) 0.13
{
Range 32–75 23–85 23–85 23–85
Years since MS diagnosis
Mean (SD) 11 (7) 14 (8) 0.00
{ 13 (8) 13 (8) 0.82
{
Range 2–30 1–53 1–53 2–42
Marital status N (%)
Married/in partnership 117 (80) 297 (80) 1.00* 414 (80) 203 (82) 0.76*
No partnership 31 (20) 75 (20) 106 (20) 46 (18)
Educational level (highest) N (%)
Primary school/vocational training 42 (28) 112 (30) 710.3 to 6.5
{ 154 (29) 74 (30) 77.1 to 7.4
{
Secondary school/vocational training 59 (40) 151 (40) 710.4 to 7.8
{ 210 (40) 95 (38) 75.6 to 9.9
{
High school/vocational training 41 (28) 90 (24) 74.9 to 11.5
{ 131 (25) 64 (26) 78.6 to 5.1
{
University 7 (5) 20 (5) 74.3 to 4.2
{ 27 (5) 16 (6) 75.2 to 2.6
{
Employment status N (%)
In training or studying 4 (3) 15 (4) 74.3 to 2.8
{ 21 (4) 10 (4) 73.6 to 3.1
{
Employed 30 (20) 82 (22) 79.2 to 5.9
{ 112 (21) 55 (22) 76.9 to 6.3
{
Voluntary work 15 (10) 18 (5) 4.0 to 11.0
{ 33 (6) 14 (6) (4.8 to 2.7
{
Partially/totally retired due to MS 95 (62) 232 (62) 78.7 to 9.4
{ 327 (62) 149 (59) 75.6 to 10.0
{
Housewife/househusband 51 (33) 113 (30) 74.5 to 13.0
{ 164 (31) 83 (33) 75.4 to 9.6
{
Retired due to age 9 (6) 33 (9) 72.6 to 7.2
{ 42 (8) 23 (9) 75.3 to 4.0
{
*Mann Whitney-Wilcoxon Rank sum test.
{Fisher exact test.
{
Difference of proportions test (95% CI) [6].
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.limited). To assess disease progression, respondents
were asked to choose the best suitable response
option out of ﬁve brieﬂy described disease courses to
identify whether patients had a stable (with or
without relapses), slowly progressive (with or without
relapses) or rapidly progressive disease course during
the preceding 6 months [11]. Because the MS
progression subgroups are based on self-reports,
they are similar but not equal to distinctions in
disease progression made by neurologists.
QOL measures
QOL was assessed by two generic HRQOL mea-
sures, the SF-36 and the WHOQOL-BREF.
SF-36 consists of eight scales and two separate
questions covering physical, psychological and social
aspects of health [9]. For each dimension, item
scores are coded, summed and transformed to a
scale with a range from 0 (worst health) to 100 (best
health). In a previous Dutch study among MS
patients [12], the SF-36 showed satisfactory levels
of internal consistency: Cronbach’s a ranged be-
tween 0.74 and 0.96.
The WHOQOL-BREF [8] was the second QOL
measure applied in this study. The WHOQOL-
BREF consists of 26 items divided into four domains
covering physical, psychological, social and environ-
mental aspects and has two single item questions.
For each scale, item scores were coded, summed and
transformed to a scale with a range from 0 (worst
health) to 20 (best health). In a previous Dutch study
[13], the WHOQOL-BREF showed satisfying levels
of internal consistency: Cronbach’s a ranged be-
tween 0.66 and 0.80. In our study, Cronbach’s a
ranged between 0.63 and 0.81.
Analyses
Scale construction
For further development of the MSIP-DP scales, we
conducted a Conﬁrmatory Factor Analysis (CFA),
using the LInear Structural Relations (LISREL)
programme, to conﬁrm the hypothesised MSIP-DP
domains that correspond with the MSIP-D domains.
Two models were tested. These were the three-factor
model for the ICF-Body Functions items and a two-
factor model for the ICF-activity component. These
models corresponded with the MSIP-D domain
constructs for body functions and activities. Applica-
tion of CFA to the ICF-Participation and the ICF
Environmental Factors components items was not
relevant because of these domains’ one-factor solu-
tion in the MSIP-D.
Model ﬁt was assessed using multiple criteria as
suggested by Schermelleh-Engel et al. [14] – (1) a
non-signiﬁcant w
2 statistic indicating that a non-
signiﬁcant amount of variance remains unexplained;
(2) a measure for overall ﬁt, the root mean square
error of approximation 40.08 with conﬁdence
interval; (3) descriptive measures – the Normed Fit
Index 50.90, the Non-normed Fit Index  0.95 and
the Comparative Fit Index  0.95.
Reliability
For conﬁrmation of the factor solutions, we exam-
ined internal consistency with Cronbach’s a for each
domain [15,16] and mean inter-item correlation
coefﬁcient (MICC) among the items [17]. A
Cronbach’s a was considered sufﬁcient if  0.70
[15]. MICCs should preferably fall in an optimal
range between 0.20 and 0.50, but should not be less
than 0.15 [7,18,19].
Test-retest reliability or stability was examined
using descriptive statistics, paired-samples t-tests
with related p-values and one-way random Intra-
class correlation coefﬁcients (ICCs) [16]. An ICC
was considered sufﬁcient if  0.80 [15].
Interrelation between MSIP-DP and MSIP-D domains
Dependency of MSIP-DP and the linked MSIP-D
scales was examined with Pearson’s correlation coefﬁ-
cient (two sided). Moderate correlation coefﬁcients
(r¼0.30–0.70) and explained variance (R
2) values
below 0.50 were considered sufﬁcient to indicate that
distinct concepts were being measured [20].
Regression analyses
To test the hypothesis that DP explains a statistically
signiﬁcant part of QOL in MS when controlling for
disease severity, a series hierarchical regression
analyses was conducted with each of the QOL scale
variables as dependent variables. On the basis of
statistically signiﬁcant correlations of the most
important background variables (age, gender, marital
status and educational level) with the QOL depen-
dent variables, age was included as co-variate for ﬁve
QOL variables, and educational level as co-variate
for two QOL variables. Before entering variables into
the analysis, dummy-variables were generated for the
categorical variables (MS progression and educa-
tional level). Relevant co-variates and the disease
severity variables were entered in the regression
model in the ﬁrst step and the MSIP-DP variables
(all in one) in the second step to determine whether
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.they explained a signiﬁcant percentage of the
variance in QOL. The expected direction of stan-
dardised b weights is negative meaning that perceiv-
ing disabilities as less problematic attributes to better
QOL.
Results
The PA and UH samples were similar for most
background characteristics (see Table I) but differed
for the number of years since receiving the MS
diagnosis: in the PA sample this was 11 years
(SD¼7) and in the UH-sample this was 14 years
(SD¼8). Furthermore, patients of the PA sample
were more likely to be in voluntary work. Patients
from the UH sample who participated in the test-
retest procedure only differed from the overall UH
sample insofar as there was a statistically signiﬁcant
higher proportion for women.
Conﬁrmatory Factor Analysis
Results of the CFA (see Table II) indicated a good-
model-ﬁt on the three factor solution for the ICF-
Body functions domains indicated by all ﬁve model
ﬁt criteria. For the two factor solution for the
ICF-activities domains, model ﬁt was acceptable
considering the good ﬁt results for four out of ﬁve
criteria for model ﬁt.
Reliability
The internal consistency of ﬁve MSIP-DP scales was
good (Table III). For the ‘mental functions’ and
‘environmental factors’ scales a was acceptable, given
the small number of items and good MICC. The
ﬁnal version of the MSIP-DP consists of seven scales
and 36 items, including the four single impairment
items. Test-retest analysis demonstrated no statisti-
cally signiﬁcant change over time for six MSIP
scales, indicating stability between both measure-
ment moments (Table III). Although the paired t-
test results for the ‘muscle and movement functions’
scale showed a statistically signiﬁcant change, this
change was, according to Cohen’s thresholds, trivial
in magnitude, as evidenced by the effect sizes
(ES¼0.12). Six MSIP-DP scales showed good
ICCs, afﬁrming sufﬁcient stability. ICC for the
‘environmental factors’ scale was moderate.
Interrelation between MSIP-DP and MSIP-D domains
Scale scores for the linked MSIP-D and MSIP-DP
scales (Table III) were moderately correlated (0.49–
Table II. Conﬁrmatory factor analysis for MSIP-DP domains.
X
2 (p-value) df RMSEA (CI) NFI NNFI CFI n
ICF-Body function component* 31.51 (0.41) 30 0.013 (0.00 to 0.045) 0.99 1.00 1.00 319
ICF-activities component
{ 68.17 (0.00) 39 0.039 (0.023 to 0.054) 1.00 1.00 1.00 488
*Three-factor model domains: Muscle and movement functions, excretion and reproductive functions and mental functions.
{Two-factor model domains: Basic movement activities, Activities of daily living.
RMSEA: Root Mean Square Error of Approximation; CI: Conﬁdence Interval; NFI: Normed ﬁt Index; NNFI: Non-normed ﬁt Index; CFI:
Comparative ﬁt Index.
Table III. Descriptive statistics and reliabilities for MSIP-DP scales.
Reliability Test-retest
MSIP–disability
KnMean (SD) a MICC t-value (p-value) ICC R/R
2
MSIP-disability perception*
Muscle and movement functions 4 515 4.4 (3.2) 0.88 0.64 2.92 (0.004){ 0.89 0.69/0.48
Excretion and reproductive functions 3 433 3.1 (2.5) 0.74 0.49 1.61 (0.109) 0.91 0.59/0.35
Mental functions 3 424 2.5 (2.1) 0.65 0.39 1.27 (0.205) 0.91 0.53/0.28
Basic movement activities 5 538 4.1 (4.4) 0.91 0.66 0.48 (0.629) 0.93 0.61/0.37
Activities of daily living 8 546 6.4 (6.7) 0.93 0.62 1.78 (0.077) 0.96 0.49/0.24
Participation in life situations 5 492 2.7 (3.3) 0.79 0.43 1.95 (0.053) 0.90 0.54/0.29
Environmental factors 4 451 0.5 (0.0) 0.50 0.20 1.19 (0.235) 0.54 0.63/0.40
K: Number of items; n: Number of respondents; SD: standard deviation; a: Cronbach’s a MICC: Mean inter-item correlation coefﬁcient;
ICC: Intra-class correlation (one-way random); R: Pearsons correlation coefﬁcient (two sided); R
2: explained variance.
*Higher scores¼more problem perception.
{Effect size¼0.12.
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.0.69) and explained variance was below 0.50
indicating that the linked scales measured related
but distinct constructs.
Impact of the perception of disabilities on the SF-36
variables
Table IV shows the results of the regression analysis
designed to ascertain the role of DP in the prediction
of QOL measured on the eight SF-36 scales. DP
variables explained a statistically relevant and unique
segment of the variance in all SF-36 variables,
particularly for the social functioning, mental health
andbodilypainvariables,butwiththeexceptionofthe
role physical variable. Most statistically signiﬁcant b
weights were in the expected negative direction. Beta
weights showed that the perception of impairments in
mental function is the most signiﬁcant predictor for
ﬁve SF-36 variables, meaning that patients who
perceived their impairments in mental functions
(cognitive, emotional and sleep functions) as less
problematicreportedabetterQOL.Theperceptionof
restrictions in life situations (mobility, personal care,
informal social relationships, employment and
re-creation) was an important predictor of the quality
ofsocialfunctioning.ConcerningthesingleMSIP-DP
items, perception of pain was a statistically signiﬁcant
predictor in the bodily pain QOL domain, whereas
perception of impairment in seeing functions was a
signiﬁcant predictor of the quality of general health.
Fatigue was a statistically signiﬁcant predictor of
vitality. Unexpected were the positive betas for (1)
the perception of impairments in muscle and move-
ment functions in predicting the SF-36 general health
domain, (2) the perception of limitations in basic
movementactivitiesinthementalhealthQOLdomain
and (3) the perception of fatigue in the quality of
physical functioning domain.
Impact of the perception of disabilities on the WHOQOL-
BREF variables
The results of the regression analysis to determine
the effect of DP on QOL, measured by the
four WHOQOL-BREF domains, are presented in
Table V. The DP variables explain a unique segment
of the variance in all four QOL domains. The most
statistically signiﬁcant b weights were in the expected
Table IV. Hierarchical multiple regression of MSIP-DP dimensions and perception of impairment items on the SF-36 scales.
SF-36
Physical
functioning
(b)
Role
physical
(b)
Bodily
pain
(b)
General
health
(b)
Vitality
(b)
Social
functioning
(b)
Role
emotional
(b)
Mental
health
(b)
MSIP-disability perception
Perception of impairments in ...
Muscle and movement
functions
70.18 70.09 70.14 0.52**
(70.13)
70.04 70.07 70.13 70.17
Excretion and reproductive
functions
70.08 70.04 70.02 70.21 70.18 0.05 0.27 70.03
Mental functions 0.10 70.18 70.33** 70.15 70.24* 70.33** 70.31* 70.50***
Perception of limitations in ...
Basic movement activities 70.09 0.18 0.21 70.37 70.08 0.27 0.03 0.55*
(70.20*)
Activities of daily living 70.24 70.10 70.06 0.14 0.06 70.36 70.31 70.32
Perception of restrictions in ...
Participation in life situations 70.10 70.16 0.07 70.03 70.05 70.30* 70.17 70.24
Perception of lack of support from ...
Environmental factors 70.12 0.07 0.09 70.05 70.04 0.13 70.08 70.07
Perception of impairments
Fatigue 0.36*** (0.02) 70.10 0.09 70.19 70.21* 0.02 70.01 70.01
Pain 70.08 70.17 70.56*** 70.09 0.12 70.09 0.04 70.04
Perception of impairment
in speech functions
0.02 0.08 70.05 70.01 0.01 70.08 0.02 0.08
Perception of impairment
in seeing functions
70.03 70.12 70.09 70.25* 70.10 70.14 0.02 70.09
Adjusted R
2 0.67 0.44 0.61 0.45 0.58 0.54 0.29 0.41
R
2 change 0.29 0.17 0.54 0.28 0.17 0.45 0.24 0.39
F 9.49*** 4.19*** 8.07*** 4.77*** 7.41*** 6.48*** 2.90** 4.25***
F change 5.38*** 1.84 8.58*** 3.22** 2.50* 6.16*** 2.15* 4.15***
*p50.05; **p50.01; ***p50.001.
In bold: statistically signiﬁcant b values and R
2 change values. Between brackets: b value when analysed as a single explaining variable.
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.negative direction. Standardised betas showed that
the perception of impairments in mental functions
was a signiﬁcant predictor for all QOL variables,
except for social relationships, and was even the most
signiﬁcant contributing predictor for physical health
and psychological health, meaning that patients who
perceived their impairments in mental functions as
less problematic reported better QOL. The percep-
tion of impairments in excretion and reproductive
functions was a signiﬁcant predictor of psychological
health and even the most signiﬁcant predictor for the
social relationships QOL variable – patients who
perceived these impairments as less problematic
reported better QOL for social relationships. The
perception of restrictions in participation in life
situations was the strongest predictor for the environ-
ment QOL variable – patients who perceived fewer
restrictions in participation in, for example, mobility,
relationships, recreation or employment reported
higher QOL with regard to their environment.
Perception of lack of support from environmental
factors (family, professionals, social security and
health services) also contributed to a statistically
signiﬁcant proportion of the explanation of the
environment QOL domain. Finally, the perception
of pain explained a statistically signiﬁcant proportion
of QOL concerning physical health. Unexpected were
the positive betas for the perception of fatigue in the
social relationships and environment QOL domains.
Discussion
This study had two objectives. The ﬁrst was to
develop a measure reﬂecting the subjective dimen-
sion of functioning and health, the perception of MS-
speciﬁc disabilities. We succeeded in applying a
subjective dimension to the objective MSIP-Disabil-
ity measure that reﬂects the perception of reported
disabilities. We named this new section of the MSIP
as MSIP-DP. Both sections generated different
results indicating that both sections reﬂected dis-
tinct, though related, dimensions of functioning and
health. CFA demonstrated a good ﬁt for the
hypothesised MSIP-DP model, and the MSIP-DP
section turned out to be a reliable measure.
The second objective was to examine the unique
contribution of this subjective dimension of MS-
related disabilities to QOL, as we hypothesised that
apart from the disabilities, the perception of dis-
abilities explains a relevant and statistically signiﬁcant
segment of QOL in MS. We controlled for disease
severity as an estimate of disability in analysing the
impact of DP on QOL. Results in this study support
our hypothesis: the perception of disabilities ex-
plained a substantial and signiﬁcant proportion of
the variance in QOL in MS, even when the effects of
disease severity were taken into account.
The perception of impairments in mental func-
tions (cognitive, emotional and sleep functions)
Table V. Hierarchical multiple regression of MSIP-DP dimensions and perception of impairment items on the WHOQOL-BREF scales.
Physical health
(b)
Psychological health
(b)
Social relationships
(b)
Environment
(b)
WHOQOL-BREF
MSIP-disability perception
Perception of impairments in ...
Muscle and movement functions 70.07 0.06 70.03 70.06
Excretion and reproductive functions 0.03 70.15* 70.33*** 70.01
Mental functions 70.34*** 70.42*** 70.13 70.24**
Perception of limitations in ...
Basic movement activities 70.12 70.05 0.02 0.04
Activities of daily living 70.20 70.03 0.12 0.04
Perception of restrictions in ...
Participation in life situations 70.04 70.09 70.09 70.28**
Perception of lack of support from ...
Environmental factors 70.07 70.10 70.07 70.23***
Perception of impairments
Fatigue 70.02 0.07 0.21** (70.09) 0.13* (70.12*)
Pain 70.19*** 70.03 70.04 70.09
Perception of impairment in speech functions 70.02 70.03 70.03 0.11
Perception of impairment in seeing functions 0.04 0.06 70.06 0.04
Adjusted R
2 0.63 0.41 0.22 0.32
R
2 change 0.35 0.28 0.19 0.24
F 21.90*** 11.02*** 4.71*** 6.90***
F change 18.02*** 9.38*** 4.59*** 6.70***
*p50.05; **p50.01; ***p50.001.
In bold: statistically signiﬁcant b values and R
2 change values. Between brackets: b value when analysed as a single explaining variable.
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.appeared to be the most important factor in
explaining QOL – it was an important contributing
factor in eight out of twelve QOL variables. The
perception of impairments in excretion and repro-
ductive functions was a signiﬁcant explanatory factor
in two QOL aspects – social relationships (WHO-
QOL-BREF) and psychological health (WHOQOL-
BREF), which underlines the potentially signiﬁcant
psychosocial impact of impairments in urination,
defecation and sexual functions. The perception of
restrictions in participation in life situations was
the most important explanatory factor for quality of
the environment (WHOQOL-BREF) and impor-
tant to the quality of social functioning (SF-36).
These results underline the relationship between
environmental aspects as operationalised by the
WHOQOL-BREF, such as ﬁnancial resources,
home environment, transportation, accessibility of
health and social care, and transportation and the
perception of participation in life situations.
Surprisingly, we found some statistically signiﬁ-
cant positive betas (i.e. perceiving a disability as
more problematic ¼ better QOL) where negative
betas were expected. A possible explanation could be
the inter-item correlation between the MSIP-DP
variables. As we entered MSIP-DP variables ‘all in
one’ in the model, these correlations could explain
the positive betas as being a matter of confusion of
correlations between the MSIP variables. We there-
fore also introduced the MSIP-DP variables with
positive betas as a single explaining variable into the
regression model. The direction of all ﬁve betas
changed from positive to the expected negative, and
three betas became no longer statistically signiﬁcant
– perception of fatigue in social relationships
(WHOQOL-BREF), physical functioning (SF-36)
and perception of impairments in muscle and
movement functions in general health (SF-36). The
perception of limitations in basic movement activities
remained a signiﬁcant predictor in the quality of
mental health (SF-36), whereas perception of fatigue
was a signiﬁcant predictor in quality of the environ-
ment (WHOQOL-BREF).
When considering our ﬁndings concerning the
impact of the perception of MS-related disabilities on
QOL, three factors inﬂuencing the results should be
borne in mind. Firstly, the results differed for both
generic HRQOL measures applied, which underlines
the fact that the QOL ‘moving’ concept is still under
development. Secondly, a further limitation of these
measures is that they reﬂect HRQOL, which is a
limited view of the broader concept of wellbeing.
Finally, these QOL measures are probably limited as
they blend objective and subjective items and
dimensions in the measures, and therefore are not
clear in what they reﬂect – functional status or the
perception of functional status.
Strengths and limitations
We considered the possibility of applying the MSIP-
D scales in the regression analysis as measures of
disability. Despite the fact that the MSIP-D and the
MSIP-DP scales assessed distinct constructs, we
rejected this option since the perception questions
were dependent on the responses to the disability
questions with a risk of auto-correlation in regression
analysis. Therefore, we applied three generic disease-
severity items that proved to be good indicators for
overall disease severity.
Some minor issues may limit the validity of our
ﬁndings on disease severity. Disease duration based
on self-reported time since diagnosis probably
slightly underestimates the actual duration of MS
because it may take some time before the deﬁnite
diagnosis is established. Results for the extent of
limitation variable, as a single item for perceived
disease severity, might have been affected by the
known limited stability of a single-item measure [21].
However, this question, with a 10-point response
option, turned out to be a strong item in discriminat-
ing between patient subgroups [10].
Finally, a minor issue concerning our sample may
limit the representativeness of our ﬁndings – the
number of patients (5%) who reported a rapidly
progressive disease course, as is typical for primary
progressive MS, was limited. Although it is known
that a minority of patients (prevalence about 15%)
have primary progressive MS [22], this sub-
sample probably does not fully reﬂect the status of
the patients with a primary progressive disease
course.
Implications
As this is the ﬁrst study that has made an attempt to
apply a subjective dimension to the objective dimen-
sion of the ICF, further exploration of possibilities
concerning this issue should be undertaken. We
recommend exploration of the relationships between
the objective dimension of ICF, a subjective dimen-
sion of the ICF and QOL concepts. Furthermore, it
is of interest to explore the role or place of the
concept of DP in the processes of adaptation and
adjustment to a chronic disease.
In this study, we examined the construct validity
with CFA, the internal consistency and test-retest
reliability of the MSIP-DP scales with satisfactory
results. Therefore, the MSIP-DP, in combination
with the MSIP-D version, can be used as an outcome
measure to assess the present disability and DP.
However, further research should examine the
treatment-related sensitivity to change (responsive-
ness) of the MSIP-DP.
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.The results of DP measurement may have im-
portant consequences in clinical practice. This easy to
apply, self-report measure for DP is designed to
detect individual patients’ problems in the perception
of disabilities, and as such it provides a basis for
shared clinical decision-making between the patient
and the health professional, in identifying patient
priorities in treatment and care and in facilitating the
setting of realistic treatment goals. In our clinical
practice, for example, both versions of the MSIP (D
and DP) are used to develop an integrated and
patient-centred care plan. The procedure is as follows
– patients prepare themselves for a consultation [with
a nurse specialist (NS)] by ﬁlling out the MSIP,
which they receive by mail about 2 weeks before the
consultation. The NS prepares her- or himself for the
consultation by studying the completed question-
naire, which is sent back by the patient before the
consultation. During the consultation, the MSIP is
used as a tool to bring up the most important issues
and to stimulate a good consultation with a full
assessment. We tested the MSIP feasibility in a pilot
study with seven NSs and 62 MS-patients during
three consultations for each patient. As a result, the
MSIP seemed to have added value in the enhance-
ment of the role and inﬂuence of MS-patients during
a consultation: patients seemed to be better prepared
and NSs reported gaining better insight into patient
health problems.
To improve a patient’s perceived QOL; health
professionals should not only focus on the interven-
tions aimed at disabilities but also on a patient’s
perception of these disabilities. Psychological inter-
ventions, for example, to prevent depression or to
improve autonomy, may support the perception
of disabilities as being less problematic and im-
prove QOL.
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.Addendum
Examples of MSIP-disability and MSIP-disability perception questions
MSIP-Disability Questions MSIP-Disability Perception Questions
Do you face impairment in your urination functions?* (e.g. frequency
of urination, incontinence, difﬁculties with urination) (b620)
0¼no, not at all. If ‘yes’, do you perceive this impairment as problematic?
1¼yes, I have a slight impairment. 0¼no, never.
2¼yes, I have a moderate impairment. 1¼yes, sometimes.
3¼yes, I have a severe impairment. 2¼yes, frequently.
4¼yes, I have a complete impairment. 3¼yes, always.
Do you face limitations in preparing meals?
{ (a630)
0¼No
1¼Yes, but assistance devices and/or adaptations are not necessary If ‘yes’, do you perceive this limitation as problematic?
2¼Yes, and assistance devices and/or adaptations are necessary 0¼no, never.
3¼Yes, and assistance devices and/or adaptations and another
person’s help are necessary.
1¼yes, sometimes.
2¼yes, frequently.
3¼yes, always.
Are there obstacles in your environment that complicate
your participation in community, recreation and leisure?
{
(e.g. accessibility of clubs or associations) (p910/p920)
0¼no
1¼Yes, as a consequence I have some trouble with ... If ‘yes’, do you perceive this obstacle as problematic?
2¼Yes, as a consequence I have trouble with ... 0¼no, never.
3¼Yes, as a consequence I have a lot of trouble with ... 1¼yes, sometimes.
4¼Yes, as a consequence ... is (nearly) impossible. 2¼yes, frequently.
3¼yes, always.
Is your relationship with your immediate family supportive to
you?
x (e.g. partner, children, parents, brothers, sisters) (e310) If ‘no’, do you perceive this lack of support as problematic?’
0¼Yes, (very) supportive. 0¼no, never.
2¼Yes, somewhat supportive. 1¼yes, sometimes.
4¼No, not supportive. 2¼yes, frequently.
3¼yes, always.
*Body function impairment question.
{Activity limitation question.
{Participation obstacle question.
xEnvironmental support question.
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